ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 159,63
0,43%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Clearmind Medicine Inc (CMND)

  7. Clearmind Medicine Inc (CMND) Actualités

CMND Clearmind Medicine Inc

1,14
-0,0301 (-2,57%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Clearmind Medicine Inc CMND NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,0301 -2,57% 1,14 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,20 1,15 1,23 1,19 1,1701
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
30/4/202422:15GLOBEClearmind Applies to Cease Being a Reporting Issuer in..
17/4/202413:49GLOBEClearmind Medicine Announces Exclusive Licensing Agreement..
10/4/202413:17GLOBEClearmind Medicine Files U.S. Patent Application for..
09/4/202414:07GLOBEClearmind Medicine CEO Issues Letter to Shareholders
19/3/202412:55GLOBEBreakthrough in Wellness: Clearmind Medicine's Psychedelic..
13/3/202413:14GLOBEClearmind Medicine Obtains Clearance for its Psychedelic-..
13/3/202412:30GLOBEClearmind Medicine Received Approval for a Voluntary..
27/2/202413:58GLOBESciSparc-Clearmind Partnership Yields Three New..
23/2/202413:06GLOBEClearmind Medicine Receives Approval to Commence its Phase..
20/2/202413:14GLOBESciSparc and Clearmind Continue to Strengthen International..
05/2/202413:51GLOBEClearmind Medicine Receives Patent Approval for its..
01/2/202414:15GLOBEClearmind Medicine Announces Exclusive, Long-Term Licensing..
16/1/202417:19GLOBEClearmind Medicine Inc. Closes US$2.4 Million Registered..
11/1/202415:28GLOBEClearmind Medicine Inc. Announces Pricing of $2.4 Million..
10/1/202413:18GLOBEClearmind Medicine Completed Type A Meeting with the FDA
04/1/202413:18GLOBEClearmind Medicine and SciSparc Reflect on Successful..
14/12/202314:26GLOBEClearmind Medicine Announces It Is In Compliance with All..
05/12/202314:47GLOBEClearmind Medicine Achieved Positive Results in Cocaine..
01/12/202314:14GLOBEWeight loss MEAI: Clearmind Medicine’s Novel Obesity Drug..
28/11/202314:25GLOBEClearmind Medicine Announces Positive Results from its..
27/11/202314:55GLOBEClearmind Medicine to Participate in Traditional vs. Novel..
21/11/202314:15GLOBEClearmind Medicine Announces 1-for-30 Reverse Share Split
17/11/202322:15GLOBEClearmind Medicine Announces Receipt of Nasdaq Delisting..
15/11/202313:37GLOBEClearmind Medicine Announces Shareholders Meeting Results
09/11/202315:20GLOBEClearmind Medicine to Pioneer Psychedelic Clinical Trials..
05/10/202315:00GLOBEClearmind Medicine to Present at the 8th Annual Dawson James..
21/9/202315:35GLOBEDawson James Securities Announces October Date for 8th..
18/9/202318:16GLOBEClearmind Medicine Closes US$2.25 Million Public Offering
14/9/202315:23GLOBEClearmind Medicine Announces Pricing of US$2.25 Million..
06/9/202315:20GLOBEClearmind Medicine Announces Clinical Research Collaboration..
14/8/202314:25GLOBEClearmind Medicine Announces Collaboration with CTS Ltd., a..
01/8/202315:00GLOBESciSparc and Clearmind Collaboration Continues to Increase..
17/7/202322:15GLOBEClearmind Medicine Announces Share-Based Payment for the..
11/7/202314:30GLOBEDr. Fatima Cody Stanford, Associate Professor of Medicine..
16/6/202315:05GLOBEClearmind Medicine and SciSparc to Conduct Study Evaluating..
09/6/202315:30GLOBEClearmind Medicine to Host Virtual Investor Conference on..
22/5/202314:30GLOBEClearmind Medicine Announces First US Site for its Phase..
19/5/202322:15GLOBEClearmind Medicine Announces Receipt of Nasdaq Minimum Bid..
17/5/202315:00GLOBEClearmind Medicine to Host Virtual Investor Conference on..
12/5/202315:00GLOBEClearmind Medicine Announces IRB Approval to Conduct..
09/5/202322:15GLOBEClearmind Medicine Retains Crescendo Communications LLC. for..
08/5/202314:30GLOBEClearmind Medicine Strengthens Scientific Advisory Board..

Dernières Valeurs Consultées

NASDAQ
CMND
Clearmind Medicine
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés